Iron removal with phlebotomy and recombinant human erythropoietin in secondary hemochromatosis after allogeneic bone marrow transplantation.
Cho
Su Jin
SJ
Department of Pediatrics, Ewha Womans University College of Medicine, Yangchon-gu, Seoul, Korea.
Lee
Soo Jeong
SJ
Yoo
Eun Sun
ES
Ryu
Kyung-Ha
KH
Seoh
Ju Young
JY
Hong
Ki Sook
KS
Koo
Heasoo
H
D001219:Aspartate Aminotransferases / Q000097:blood; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005293:Ferritins / Q000097:blood; D006086:Graft vs Host Disease; D006432:Hemochromatosis / Q000097:blood / Q000628:therapy*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000601:surgery; D008111:Liver Function Tests; D009190:Myelodysplastic Syndromes / Q000601:surgery; D018962:Phlebotomy; D011994:Recombinant Proteins
D011994:Recombinant Proteins; D004921:Erythropoietin; D005293:Ferritins; D001219:Aspartate Aminotransferases